Anticarcinogenesis and Radiation Protection 2 1991
DOI: 10.1007/978-1-4615-3850-9_40
|View full text |Cite
|
Sign up to set email alerts
|

Antimutagenic and Anticarcinogenic Mechanisms of Aminothiols

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

1991
1991
2014
2014

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 26 publications
0
11
0
Order By: Relevance
“…8). The unusual high reactivity of cysteine with ROS is the reason why it is often used as an antioxidant [84].…”
Section: Further Important Reactions Of Omentioning
confidence: 99%
“…8). The unusual high reactivity of cysteine with ROS is the reason why it is often used as an antioxidant [84].…”
Section: Further Important Reactions Of Omentioning
confidence: 99%
“…[1][2][3] Research has shown that N-AC has potential both as a chemo-preventative agent and as a treatment in certain types of cancer, including lung, skin, head, neck, mammary, and liver cancers. 4,5 The determination of N-AC has been established by such methods as chromatography, [6][7][8] spectrophotometry, [9][10][11][12] fluorimetry, 13 flow injection, 14 and electrochemical methods. 15,16 Folic acid (FA) is a water-soluble vitamin.…”
Section: Introductionmentioning
confidence: 99%
“…Chromium(VI) is an established carcinogen , and a potent mutagen for bacterial and mammalian cells. , The generally accepted mechanism for the biological action of Cr(VI) − includes the following: (i) uptake by cells through anion channels (for [CrO 4 ] 2- ) or through phagocytosis (for insoluble chromates); (ii) intracellular reduction of Cr(VI) to Cr(III) with the formation of reactive Cr(V), Cr(IV), and free radical intermediates, capable of damaging DNA; (iii) stabilization of Cr(V) and Cr(IV) species by intracellular ligands such as 1,2-diolates and 2-hydroxycarboxylates; and (iv) formation of kinetically inert Cr(III) complexes with biological macromolecules as the products of Cr(VI) reductions. Glutathione (GSH) and ascorbate are the most likely intracellular reductants of Cr(VI); , therefore, their ability to stabilize the Cr(V) oxidation state 11-16 is important in relation to Cr(VI)-induced genotoxicity and carcinogenicity. , Formation of Cr(V) complexes during the reactions of Cr(VI) with GSH has been studied by EPR spectroscopy; − however, the nature of these Cr(V) species remained unclear .…”
Section: Introductionmentioning
confidence: 99%